- Free UK next-day delivery on orders over £75
Weight-loss peptides have become one of the most researched areas in metabolic science. Researchers are studying how these compounds interact with hormones and receptors involved in appetite, energy balance, and glucose metabolism to better understand how the body regulates weight.
Among the most talked about compounds is Retatrutide, a next generation peptide that works differently from earlier GLP-1 therapies by targeting multiple receptors. As research continues to develop, scientists are gaining a better understanding of how these peptides may influence metabolic pathways.
In this guide, we’ll explain what weight loss peptides are, how GLP-1 peptides work, what makes Retatrutide different, and why these compounds continue to attract attention in scientific research.
Weight loss-peptides are compounds that researchers study to better understand how the body regulates appetite, metabolism, energy balance, and blood sugar. Many are designed to mimic naturally occurring hormones, allowing scientists to investigate how specific biological pathways work.
One of the best-known groups is GLP-1 peptides. GLP-1, or glucagon-like peptide-1, is a hormone naturally released by the gut after eating. It helps regulate appetite, supports insulin release when blood sugar rises, and slows how quickly the stomach empties. These natural processes are why GLP-1 has become such an important focus of metabolic research.
Research has continued to evolve beyond GLP-1 alone. Newer compounds such as Retatrutide are being investigated because they target multiple receptors involved in metabolic regulation, including GLP-1, GIP, and glucagon receptors. This has made them a significant area of interest in both preclinical and clinical research.
If you’re interested in learning more about these compounds, you can also explore our Weight Loss Peptides category, including Retatrutide, AOD 9604, 5-Amino-1MQ, MOTS-C, NAD+, and Tesamorelin, all supplied as research grade products for laboratory use.
GLP-1, short for glucagon-like peptide-1, is a hormone naturally produced in the intestine after eating. It forms part of the body’s incretin system, which helps regulate blood glucose levels by increasing insulin release when blood sugar rises. GLP-1 also slows the rate at which the stomach empties and sends signals to the brain that contribute to feelings of fullness.
Because of these natural functions, GLP-1 has become an important area of scientific research. Researchers study GLP-1 receptor agonists, which are compounds designed to activate the same receptor as the naturally occurring hormone. These studies aim to improve our understanding of metabolism, hormone signalling, glucose regulation, and energy balance.
Research has continued to evolve with the development of newer peptides that act on multiple receptors. For example, Retatrutide is being investigated for its activity at the GLP-1, GIP, and glucagon receptors, while compounds such as AOD 9604 and Tesamorelin are also being researched for their roles in metabolic science. Together, these compounds continue to expand our understanding of how peptide signalling influences metabolic pathways.
Retatrutide is a next-generation research peptide that is currently being studied for its effects on metabolic regulation. Unlike earlier compounds that target a single receptor, Retatrutide is designed to activate three different receptors involved in energy balance and glucose metabolism: GLP-1, GIP, and glucagon receptors. This is why it is often referred to as a triple receptor agonist.
Researchers are investigating Retatrutide to better understand how activating these three pathways together may influence metabolic processes compared with earlier GLP-1 receptor agonists. Current studies are exploring its role in appetite regulation, energy expenditure, glucose control, and overall metabolic function, although research is still ongoing.
At Peptides Medic, we supply research grade Retatrutide for laboratory use in a range of strengths, including Retatrutide 20mg Vial, Retatrutide 40mg Vial, Retatrutide 60mg Vial, Retatrutide 20mg Pen, Retatrutide 40mg Pen, and Retatrutide 60mg Pen. Every batch is independently HPLC tested to verify purity and consistency before dispatch.
Retatrutide is different from earlier metabolic peptides because it is designed to activate three receptors rather than one. These are the GLP-1, GIP, and glucagon receptors, all of which play important roles in how the body regulates energy and metabolism. This combination is why Retatrutide is known as a triple receptor agonist.
The GLP-1 receptor is involved in regulating blood glucose, slowing gastric emptying, and sending signals that contribute to feelings of fullness. The GIP receptor is also involved in glucose regulation and energy metabolism, while the glucagon receptor plays a role in energy expenditure and metabolic function. Researchers are studying how activating all three receptors together may produce different biological effects compared with compounds that target only the GLP-1 receptor.
Current research is exploring Retatrutide’s potential role in metabolic regulation, appetite signalling, glucose metabolism, and energy balance. While studies continue to develop, its unique mechanism of action has made it one of the most closely watched peptides in metabolic research. More information on the clinical research can be found in the New England Journal of Medicine.
The quality of a research peptide can have a significant impact on laboratory studies. Choosing products from a trusted supplier helps ensure consistency, reliability, and confidence in your research.
When selecting a research peptide, it’s worth looking for a few key indicators of quality:
At Peptides Medic, every peptide is independently HPLC tested before dispatch and supplied for laboratory research purposes only. Whether you’re researching Retatrutide, NAD+, MOTS-C, or AOD 9604, our focus is on providing high-quality research compounds backed by reliable service and transparent quality control.
Weight loss peptides continue to be one of the most active areas of metabolic research, with compounds such as Retatrutide helping researchers better understand how different hormone pathways work together. As scientific knowledge continues to grow, these compounds are providing valuable insights into appetite regulation, energy balance, and glucose metabolism.
Whether you’re researching Retatrutide, AOD 9604, MOTS-C, NAD+, or other compounds from our Weight Loss Peptides range, choosing high quality research grade products is essential. At Peptides Medic, every peptide is independently HPLC tested to provide the consistency and quality researchers expect.
Find answers to some of the most common questions about weight loss peptides, GLP-1 research, and Retatrutide.
Retatrutide is a research peptide that activates the GLP-1, GIP, and glucagon receptors. It is currently being studied in metabolic research to better understand its effects on energy balance, glucose metabolism, and hormone signalling. You can explore our Retatrutide research products to learn more.
Traditional GLP-1 peptides activate only the GLP-1 receptor. Retatrutide is different because it targets three receptors at the same time: GLP-1, GIP, and glucagon. Researchers are investigating whether this multi-receptor approach produces different effects compared with earlier GLP-1 receptor agonists.
Many peptides, including Retatrutide, are currently being investigated in ongoing scientific and clinical research. Their use depends on the specific compound and the purpose of the study. At Peptides Medic, all products are supplied strictly for laboratory research purposes only and are not intended for human or veterinary use.
Look for suppliers that provide independent HPLC testing, clear product information, and transparent quality standards. At Peptides Medic, every peptide is independently tested for purity before dispatch, helping researchers source reliable compounds for laboratory studies. Browse our full range of Weight Loss Peptides to explore the available products.
